Iterum Therapeutics plc
ITRM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $24 | $6 | $21 | $27 |
| Short-Term Investments | $0 | $18 | $40 | $54 |
| Receivables | $0 | $0 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $1 |
| Total Curr. Assets | $25 | $26 | $62 | $83 |
| Property Plant & Equip (Net) | $0 | $1 | $2 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $20 | $0 | $2 | $3 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $1 | $1 |
| Total NC Assets | $20 | $1 | $4 | $8 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $45 | $26 | $67 | $92 |
| Liabilities | – | – | – | – |
| Payables | $0 | $5 | $3 | $1 |
| Short-Term Debt | $14 | $0 | $0 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $9 | $6 | $10 |
| Total Curr. Liab. | $18 | $14 | $9 | $13 |
| LT Debt | $31 | $19 | $30 | $28 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $31 | $19 | $30 | $28 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $1 | $3 |
| Total Liabilities | $49 | $33 | $39 | $41 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $2 |
| Retained Earnings | -$486 | -$461 | -$423 | -$378 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $482 | $455 | $451 | $427 |
| Total Equity | -$4 | -$6 | $28 | $50 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $45 | $26 | $67 | $92 |
| Net Debt | $21 | $13 | $9 | $3 |